Patents Assigned to The University of Queensland St. Lucia
  • Patent number: 8293812
    Abstract: The invention provides a polymer composite comprising a thermoplastic host polymer having solid particulate material dispersed therethrough, the host polymer having at least one phase nanodomain, wherein the solid particulate material comprises particles having height, length and width dimensions of which at least one is substantially less than one or both of the other dimensions, and wherein the composite exhibits an increase in modulus of no more than 15% and a higher tensile strength, relative to said host polymer.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: October 23, 2012
    Assignee: The University of Queensland St. Lucia
    Inventor: Darren James Martin
  • Publication number: 20110207181
    Abstract: The invention is directed to novel enzymes that convert sucrose to isomaltulose. More particularly, the present invention discloses novel sucrose isomerases, polynucleotides encoding these sucrose isomerases, methods for isolating such polynucleotides and nucleic acid constructs that express these polynucleotides. Also disclosed are cells, including transformed bacterial or plant cells, and differentiated plants comprising cells, which contain these sucrose isomerase-encoding polynucleotides, as well as extracts thereof. Methods of producing isomaltulose are also disclosed which use the polypeptides, polynucleotides, cells, cell extracts and plants of the invention.
    Type: Application
    Filed: February 8, 2011
    Publication date: August 25, 2011
    Applicant: The University of Queensland, St. Lucia
    Inventors: Robert George BIRCH, Luguang WU
  • Patent number: 7977082
    Abstract: The invention is directed to novel enzymes that convert sucrose to isomaltulose. More particularly, the present invention discloses novel sucrose isomerases, polynucleotides encoding these sucrose isomerases, methods for isolating such polynucleotides and nucleic acid constructs that express these polynucleotides. Also disclosed are cells, including transformed bacterial or plant cells, and differentiated plants comprising cells, which contain these sucrose isomerase-encoding polynucleotides, as well as extracts thereof. Methods of producing isomaltulose are also disclosed which use the polypeptides, polynucleotides, cells, cell extracts and plants of the invention.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: July 12, 2011
    Assignee: The University of Queensland of St. Lucia
    Inventors: Robert George Birch, Luguang Wu
  • Publication number: 20090214473
    Abstract: A method of treating multiple sclerosis (MS) is provided which includes the step of administering a pharmaceutically-effective amount of chaperonin 10 and IFN-beta. Also provided are pharmaceutical compositions and a kit for treating MS, which include chaperonin 10 and IFN-beta.
    Type: Application
    Filed: January 29, 2009
    Publication date: August 27, 2009
    Applicant: The University of Queensland of St. Lucia
    Inventors: Halle MORTON, Alice CAVANAGH
  • Patent number: 7524654
    Abstract: The invention is directed to novel enzymes that convert sucrose to isomaltulose. More particularly, the present invention discloses novel sucrose isomerases, polynucleotides encoding these sucrose isomerases, methods for isolating such polynucleotides and nucleic acid constructs that express these polynucleotides. Also disclosed are cells, including transformed bacterial or plant cells, and differentiated plants comprising cells, which contain these sucrose isomerase-encoding polynucleotides, as well as extracts thereof. Methods of producing isomaltulose are also disclosed which use the polypeptides, polynucleotides, cells, cell extracts and plants of the invention.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: April 28, 2009
    Assignee: The University of Queensland of St. Lucia
    Inventors: Robert George Birch, Luguang Wu
  • Publication number: 20080268017
    Abstract: A method of producing a tissue includes placing a molding support within a body cavity for a time and under conditions sufficient for non-vascularized tissue comprising myofibroblasts to form on the molding support. In some embodiments, the tissue produced by this method is particularly useful as vascular tissue for the treatment or prophylaxis of diseased or damaged blood vessels such as in atherosclerosis.
    Type: Application
    Filed: May 15, 2008
    Publication date: October 30, 2008
    Applicant: The University of Queensland of St. Lucia
    Inventors: Julie H. CAMPBELL, Gordon Ronald Campbell
  • Publication number: 20080160582
    Abstract: The invention is directed to novel enzymes that convert sucrose to isomaltulose. More particularly, the present invention discloses novel sucrose isomerases, polynucleotides encoding these sucrose isomerases, methods for isolating such polynucleotides and nucleic acid constructs that express these polynucleotides. Also disclosed are cells, including transformed bacterial or plant cells, and differentiated plants comprising cells, which contain these sucrose isomerase-encoding polynucleotides, as well as extracts thereof. Methods of producing isomaltulose are also disclosed which use the polypeptides, polynucleotides, cells, cell extracts and plants of the invention.
    Type: Application
    Filed: February 2, 2006
    Publication date: July 3, 2008
    Applicant: The University of Queensland of St. Lucia
    Inventors: Robert George Birch, Luguang Wu
  • Patent number: 7250282
    Abstract: The invention is directed to novel enzymes that convert sucrose to isomaltulose. More particularly, the present invention discloses novel sucrose isomerases, polynucleotides encoding these sucrose isomerases, methods for isolating such polynucleotides and nucleic acid constructs that express these polynucleotides. Also disclosed are cells, including transformed bacterial or plant cells, and differentiated plants comprising cells, which contain these sucrose isomerase-encoding polynucleotides, as well as extracts thereof. Methods of producing isomaltulose are also disclosed which use the polypeptides, polynucleotides, cells, cell extracts and plants of the invention.
    Type: Grant
    Filed: February 27, 2003
    Date of Patent: July 31, 2007
    Assignee: The University of Queensland of St. Lucia
    Inventors: Robert George Birch, Luguang Wu
  • Publication number: 20070077569
    Abstract: The invention is directed to novel enzymes that convert sucrose to isomaltulose. More particularly, the present invention discloses novel sucrose isomerases, polynucleotides encoding these sucrose isomerases, methods for isolating such polynucleotides and nucleic acid constructs that express these polynucleotides. Also disclosed are cells, including transformed bacterial or plant cells, and differentiated plants comprising cells, which contain these sucrose isomerase-encoding polynucleotides, as well as extracts thereof. Methods of producing isomaltulose are also disclosed which use the polypeptides, polynucleotides, cells, cell extracts and plants of the invention.
    Type: Application
    Filed: February 2, 2006
    Publication date: April 5, 2007
    Applicant: The University of Queensland of St. Lucia
    Inventors: Robert Birch, Luguang Wu
  • Patent number: 7172870
    Abstract: This invention relates to treatment of papillomavirus infections. Primarily there is provided a method of treatment of an existing papillomavirus (PV) infection which includes the step of administration of PV VLPs selected from the group consisting of PV L1 VLPs and PV L1/L2 VLPs to a patient suffering from the PV infection. Suitably the PV infection is characterised by the presence of epithelial lesions. The major infection which is treated are gential warts caused by HPV 6 and HPV 11.
    Type: Grant
    Filed: March 15, 2005
    Date of Patent: February 6, 2007
    Assignee: The University of Queensland of St. Lucia
    Inventors: Ian Frazer, Xiao Yi Sun, legal representative, Jian Zhou, deceased
  • Patent number: 6867033
    Abstract: This invention relates to treatment of papillomavirus infections. Primarily there is provided a method of treatment of an existing papillomavirus (PV) infection which includes the step of administration of PV VLPs selected from the group consisting of PV L1 VLPs and PV L1/L2 VLPs to a patient suffering from the PV infection. Suitably the PV infection is characterised by the presence of epithelial lesions. The major infection which is treated are gential warts caused by HPV 6 and HPV 11.
    Type: Grant
    Filed: December 13, 1999
    Date of Patent: March 15, 2005
    Assignee: The University of Queensland of St. Lucia
    Inventors: Ian Frazer, Xiao Yi Sun, Jian Zhou
  • Publication number: 20040126404
    Abstract: The present invention relates generally to tissue implant material for use in grafting procedures. More particularly, the present invention provides non-vascular tissue for use as vascular graft material. The present invention further contemplates a method of vascular grafting using non-vascular tissue. The tissue of the present invention is preferably autologous relative to the recipient of the graft and is conveniently prepared around or on a molding support or other foreign body inserted into a body cavity of the intended recipient of the graft. The tissues and methods of the present invention are particularly useful in the treatment or prophylaxis of diseased or damaged blood vessels such as in atherosclerosis.
    Type: Application
    Filed: July 29, 2003
    Publication date: July 1, 2004
    Applicant: University of Queensland of St. Lucia
    Inventors: Julie Hazel Campbell, Gordon Ronald Campbell
  • Patent number: 6726912
    Abstract: A papillomavirus polyprotein construct comprises at least two amino acid sequences fused directly or indirectly together, each of the sequences being the sequence of an early ORF protein of papillomavirus or an immunogenic variant or fragment thereof, and at least one of said sequences being other than the E6 or E7 protein sequence or an immunogenic variant or fragment thereof. Nucleic acid molecules encoding the polyprotein construct, prophylactic or therapeutic compositions comprising the polyprotein construct or the nucleic acid molecule, and methods for eliciting an immune response against papillomavirus in a host animal are also provided.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: April 27, 2004
    Assignees: CSL Limited, University of Queensland of St. Lucia
    Inventors: Elizabeth Ann Webb, Mary Brigid Margetts, John Cooper Cox, Ian Frazer, Nigel Alan John McMillan, Mark Philip Williams, Margaret Bridget Holland Moloney, Stirling John Edwards